logo

Wanbury Ltd. Financials

15:48 May 30

Wanbury Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
297.29
+14.15 (+5.00%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Wanbury Ltd. Financials

Wanbury Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
297.29
+14.15 (+5.00%)
15:48 May 30
Quality
image/svg+xml

52/100
Medium Financial Strength

Valuation
image/svg+xml

25/100
Expensive Valuation

Technical

59/100
Technically Neutral

Strength

8

Weakness

6

Opportunity

1

Threats

0

51.50 %

ROE %

7.37 %

ROA %

9.32

EPS

18.09

BVPS

5.09 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
392.52 511.19 499.65 575.65 599.51
Operating Expenses +
374.51 475.87 476.48 505.65 523.2
Raw Material
224.35 325.07 273.46 306.52 292.96
Increase Decrease in Cost
-7.2 -24.79 29.13 -3.89 1.51
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
64.15 74.81 81 86.92 104.24
Miscellaneous Expenses
114.51 141.06 124.85 150.7 154.65
Operating Profit
18.01 35.32 23.17 70 76.31
Other Income
2.4 1.51 0.91 2.99 3.49
Depreciation
9.75 11.45 12.38 13.03 13.31
Interest
23.07 20.61 21.39 29.18 36.95
Profit before tax and exceptio..
-12.41 4.76 -9.69 30.78 29.55
Exceptional Items
0 76.37 -0.59 25.56 0
PBT
-12.41 81.13 -10.29 56.34 29.55
Provision for Taxation
0.2 -0.35 0.11 0.38 -0.98
Net Profit
-12.61 81.47 -10.4 55.96 30.53
NET Profit after MI
-12.61 81.47 -10.4 55.96 30.53
EPS
-5.04 25.29 -3.18 17.1 8.98
Operating Profit Margin (%)
4.59 6.91 4.64 12.16 12.73
Net Profit Margin (%)
-3.21 15.94 -2.08 9.72 5.09

Wanbury Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 39.80 39.80 39.80 39.80 39.80
FII 1.60 0.80 1.00 0.20 0.20
MF 0.00 0.00 0.00 0.00 0.00
Public 58.70 59.40 59.20 60.00 60.00
Others 0.00 0.00 0.00 0.00 0.00
Others -0.10 0.00 0.00 0.00 0.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: